000169841 001__ 169841
000169841 005__ 20240408152048.0
000169841 0247_ $$2doi$$a10.1016/j.jid.2021.06.017
000169841 0247_ $$2pmid$$apmid:34265330
000169841 0247_ $$2ISSN$$a0022-202X
000169841 0247_ $$2ISSN$$a1523-1747
000169841 037__ $$aDKFZ-2021-01584
000169841 041__ $$aEnglish
000169841 082__ $$a610
000169841 1001_ $$aHudemann, C.$$b0
000169841 245__ $$aHuman desmocollin 3-specific IgG antibodies are pathogenic in a humanized HLA-class II transgenic mouse model of pemphigus.
000169841 260__ $$aAmsterdam$$bElsevier$$c2022
000169841 3367_ $$2DRIVER$$aarticle
000169841 3367_ $$2DataCite$$aOutput Types/Journal article
000169841 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1712582426_11099
000169841 3367_ $$2BibTeX$$aARTICLE
000169841 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000169841 3367_ $$00$$2EndNote$$aJournal Article
000169841 500__ $$aVolume 142, Issue 3, Part B, March 2022, Pages 915-923.e3
000169841 520__ $$aPemphigus is a potentially lethal autoimmune bullous skin disorder, which is associated with IgG autoantibodies against desmoglein 3 (Dsg3) and Dsg1. Notably, a subset of pemphigus patients presents with a similar clinical phenotype in the absence of anti-Dsg IgG, suggesting the presence of serum IgG reactive with desmosomal components other than Dsg1 or Dsg3. We and others have previously shown that such patients have serum IgG autoantibodies against desmocollin 3 (Dsc3), a component of desmosomes, that induce loss of keratinocyte adhesion ex vivo. Moreover, Dsc3 hypomorphic mice show a severe blistering phenotype of the mucous membrane which is highly characteristic in pemphigus. These findings prompted us to study induction and regulation of anti-human Dsc3 IgG in humanized mice transgenic for HLA-DRB1*04:02, which is a highly prevalent haplotype in pemphigus. We show that IgG from sera of immunized mice induce acantholysis in a dispase-based keratinocyte dissociation assay via the activation of p38 mitogen-activated protein kinases and epidermal growth factor receptor. Passive IgG transfer from mice immunized with recombinant human Dsc3 into neonates did not induce intraepidermal loss of adhesion presumably due to the lack of homology between human and mouse Dsc3. Ex vivo stimulation of splenocytes from Dsc3-immunized mice with human Dsc3 leads to a significant proliferative interferon-γ and interleukin 4 T cell response, which is restricted by HLA-DR/DQ. These findings suggest that induction of pathogenic anti-Dsc3 IgG is associated with Dsc3-specific T cells that recognize Dsc3 in association with HLA-DRB1*04:02.
000169841 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000169841 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000169841 650_7 $$2Other$$aHLA
000169841 650_7 $$2Other$$aantibodies
000169841 650_7 $$2Other$$aautoimmunity
000169841 650_7 $$2Other$$adesmocollin
000169841 650_7 $$2Other$$apemphigus vulgaris
000169841 7001_ $$aMaglie, R.$$b1
000169841 7001_ $$0P:(DE-HGF)0$$aLlamazares, M.$$b2
000169841 7001_ $$aBeckert, B.$$b3
000169841 7001_ $$aDidona, D.$$b4
000169841 7001_ $$aTikkanen, R.$$b5
000169841 7001_ $$aSchmitt, T.$$b6
000169841 7001_ $$aHashimoto, T.$$b7
000169841 7001_ $$aWaschke, J.$$b8
000169841 7001_ $$aHertl, M.$$b9
000169841 7001_ $$aEming, R.$$b10
000169841 773__ $$0PERI:(DE-600)2006902-9$$a10.1016/j.jid.2021.06.017$$gp. S0022202X21014408$$n3, Part B$$p915-923.e3$$tThe journal of investigative dermatology$$v142$$x0022-202X$$y2022
000169841 909CO $$ooai:inrepo02.dkfz.de:169841$$pVDB
000169841 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000169841 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000169841 9130_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000169841 9141_ $$y2021
000169841 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-04
000169841 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-02-04
000169841 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-04
000169841 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ INVEST DERMATOL : 2021$$d2022-11-15
000169841 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-15
000169841 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-15
000169841 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-15
000169841 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-15
000169841 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-15
000169841 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-15
000169841 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-15
000169841 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-15
000169841 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-15
000169841 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ INVEST DERMATOL : 2021$$d2022-11-15
000169841 9201_ $$0I:(DE-He78)B370-20160331$$kB370$$lEpigenomik$$x0
000169841 980__ $$ajournal
000169841 980__ $$aVDB
000169841 980__ $$aI:(DE-He78)B370-20160331
000169841 980__ $$aUNRESTRICTED